Search research articles
Contact Us
Filters
Showing results (351-360 of 463) with videos related to
Page
of 47
Sort By:
Journal of Crohn'S & Colitis
|
December 22, 2010
IBD patients need in health quality of care ECCO consensus
Margarita Elkjaer, Gabrielle Moser, Walter Reinisch, et al.
The New England Journal of Medicine
|
September 29, 2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
William J Sandborn, Brian G Feagan, Geert D'Haens, et al.
Gut
|
October 21, 2020
Effect of IBD medications on COVID-19 outcomes: results from an international registry
Ryan C Ungaro, Erica J Brenner, Richard B Gearry, et al.
The American Journal of Gastroenterology
|
January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial
Bruce E Sands, David T Rubin, Edward V Loftus, et al.
Therapeutic Advances in Gastroenterology
|
November 9, 2022
COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study
Simon J Hong, Sumona Bhattacharya, Aiya Aboubakr, et al.
Gastroenterology
|
March 14, 2020
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis
Joana Torres, Francesca Petralia, Takahiro Sato, et al.
Gut
|
December 16, 2021
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
Judith Wellens, Matthew Edmans, Uri Obolski, et al.
Gut
|
February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, et al.
Journal of Crohn'S & Colitis
|
September 27, 2021
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
Amanda Ricciuto, Christopher A Lamb, Eric I Benchimol, et al.
Inflammatory Bowel Diseases
|
May 20, 2022
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course
Stephanie L Gold, Loren G Rabinowitz, Laura Manning, et al.
Page
of 47
Search research articles
Search
Showing results (351-360 of 463) with videos related to
Sort By:
Page
of 47
Journal of Crohn'S & Colitis
|
December 22, 2010
IBD patients need in health quality of care ECCO consensus
Margarita Elkjaer, Gabrielle Moser, Walter Reinisch, et al.
The New England Journal of Medicine
|
September 29, 2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
William J Sandborn, Brian G Feagan, Geert D'Haens, et al.
Gut
|
October 21, 2020
Effect of IBD medications on COVID-19 outcomes: results from an international registry
Ryan C Ungaro, Erica J Brenner, Richard B Gearry, et al.
The American Journal of Gastroenterology
|
January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial
Bruce E Sands, David T Rubin, Edward V Loftus, et al.
Therapeutic Advances in Gastroenterology
|
November 9, 2022
COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study
Simon J Hong, Sumona Bhattacharya, Aiya Aboubakr, et al.
Gastroenterology
|
March 14, 2020
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis
Joana Torres, Francesca Petralia, Takahiro Sato, et al.
Gut
|
December 16, 2021
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
Judith Wellens, Matthew Edmans, Uri Obolski, et al.
Gut
|
February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, et al.
Journal of Crohn'S & Colitis
|
September 27, 2021
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
Amanda Ricciuto, Christopher A Lamb, Eric I Benchimol, et al.
Inflammatory Bowel Diseases
|
May 20, 2022
High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course
Stephanie L Gold, Loren G Rabinowitz, Laura Manning, et al.
Page
of 47